title: Extracellular matrix of the human cyclic corpus luteum.
abstract: Extracellular matrix regulates many cellular processes likely to be important for development and regression of corpora lutea. Therefore, we identified the types and components of the extracellular matrix of the human corpus luteum at different stages of the menstrual cycle. Two different types of extracellular matrix were identified by electron microscopy; subendothelial basal laminas and an interstitial matrix located as aggregates at irregular intervals between the non-vascular cells. No basal laminas were associated with luteal cells. At all stages, collagen type IV alpha1 and laminins alpha5, beta2 and gamma1 were localized by immunohistochemistry to subendothelial basal laminas, and collagen type IV alpha1 and laminins alpha2, alpha5, beta1 and beta2 localized in the interstitial matrix. Laminin alpha4 and beta1 chains occurred in the subendothelial basal lamina from mid-luteal stage to regression; at earlier stages, a punctate pattern of staining was observed. Therefore, human luteal subendothelial basal laminas potentially contain laminin 11 during early luteal development and, additionally, laminins 8, 9 and 10 at the mid-luteal phase. Laminin alpha1 and alpha3 chains were not detected in corpora lutea. Versican localized to the connective tissue extremities of the corpus luteum. Thus, during the formation of the human corpus luteum, remodelling of extracellular matrix does not result in basal laminas as present in the adrenal cortex or ovarian follicle. Instead, novel aggregates of interstitial matrix of collagen and laminin are deposited within the luteal parenchyma, and it remains to be seen whether this matrix is important for maintaining the luteal cell phenotype.
authors.affiliation: Department of Obstetrics and Gynaecology, Research Centre for Reproductive Health, University of Adelaide, Adelaide, South Australia, Australia.
authors.forename: Helen F
authors.initials: HF
authors.lastname: Irving-Rodgers
authors.forename: Barbro E
authors.initials: BE
authors.lastname: Friden
authors.forename: Stephanie E
authors.initials: SE
authors.lastname: Morris
authors.forename: Helen D
authors.initials: HD
authors.lastname: Mason
authors.forename: Mats
authors.initials: M
authors.lastname: Brannstrom
authors.forename: Kiyotoshi
authors.initials: K
authors.lastname: Sekiguchi
authors.forename: Noriko
authors.initials: N
authors.lastname: Sanzen
authors.forename: Lydia M
authors.initials: LM
authors.lastname: Sorokin
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Sado
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Ninomiya
authors.forename: Raymond J
authors.initials: RJ
authors.lastname: Rodgers
mesh_terms: D024141:Collagen Type IV / Q000378:metabolism; D003338:Corpus Luteum / Q000378:metabolism* / Q000648:ultrastructure; D005109:Extracellular Matrix / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007797:Laminin / Q000378:metabolism; D008597:Menstrual Cycle / Q000378:metabolism*; D008854:Microscopy, Electron
chemical_list: D024141:Collagen Type IV; D007797:Laminin; C119013:laminin 10; C474559:laminin 11 protein, human; C110308:laminin 8; C404084:laminin 9